Pre tax earnings up 15%. The tax rate was down 7 percentage points and share count down 6 percentage points. Operating earnings were a little weak when you look past headline number. Hope stock does not tank.
8% of sales and 13% of prescription sales just disappeared with Express scripts non-renewal. That is a very big hurdle to overcome and will probably lead to flat earnings in 2012. That means estimates come down and the stock comes down with it. This is a mess for the stock. Who gets the ES business.